Clinical Trial Update: AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing AVANDAMET (rosiglitazone/metformin) against metformin and a sulphonylurea in adults with poorly controlled type 2 diabetes; the study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandamet (rosiglitazone/metformin)
• Glucophage (metformin)
• Sulphonylurea (sulphonylurea)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-Insulin-Dependent Diabetes Mellitus | Phase 3 | Status: COMPLETED